Having trouble accessing articles? Reset your cache.

Dec. 17 Financial Quick Takes: Lilly sets 2020 guidance; plus JOINN, ArcherDX, KeChow, Aelis and ICT

Lilly releases full-year 2020 guidance
Eli Lilly and Co. (NYSE:LLY) expects adjusted EPS of $6.70-$6.80 on revenues of $23.6-$24.1 billion in 2020, according to new guidance released Tuesday. Both ranges reflect growth expected from its current expectations of adjusted EPS of $5.75-$5.85 on $22-$22.5

Read the full 434 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE